|
2025
|
P/S
|
Pharmaceutical preparations for the treatment of ophthalmological diseases and disorders |
|
|
P/S
|
Business administration services, namely, business administration of a program to provide access ... |
|
|
P/S
|
Genetically modified cells, genome editing reagents, and biological preparations, namely, viral v... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of auditory, hematological, gastrointestinal, neuro... |
|
|
P/S
|
Promoting and supporting education and recognition initiatives in the science, technology, engine... |
|
|
P/S
|
Providing scientific information, news, and commentary in the field of pharmaceuticals; Providing... |
|
|
P/S
|
Pharmaceutical preparations. |
|
|
P/S
|
Live animals |
|
|
P/S
|
Pharmaceutical research services, namely, nucleic acid molecule development and nucleic acid mole... |
|
|
Invention
|
Methods of characterizing and purifying vegf receptor fusion protein.
Anti-VEGF proteins includi... |
|
|
P/S
|
Pharmaceutical preparations for the prevention and treatment of neuromuscular, muscular, musculos... |
|
|
Invention
|
Bracketing device for manufacturing parts cleaner and methods therefor.
A bracketing device conf... |
|
|
Invention
|
Use of raman spectroscopy in downstream purification.
In situ Raman spectroscopy methods and sys... |
|
|
Invention
|
Treatment of inflammatory conditions by delivery of interleukin-1 receptor antagonist fusion prot... |
|
|
P/S
|
Business administration services, namely, business administration of a program to provide informa... |
|
|
Invention
|
Bispecific antigen binding molecules that bind gdf8 and activin a and uses thereof. The present i... |
|
|
Invention
|
Prame off-target peptides and uses thereof. 425-433425-433425-433425-433 peptide. |
|
|
Invention
|
Off-target peptide-mhc complex conformation modeling systems and methods for antigen-recognition ... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of auditory and neurological diseases and disorders... |
|
|
Invention
|
Bispecific antigen binding molecules that bind gdf8 and activin a and uses thereof.
The present ... |
|
|
Invention
|
Materials and methods of treating mhc-1-opathy risk haplotypes.
The present disclosure provides ... |
|
|
Invention
|
Ass1 gene insertion for the treatment of citrullinemia type i. Nucleic acid constructs and compos... |
|
|
Invention
|
Ass1 gene insertion for the treatment of citrullinemia type i.
Nucleic acid constructs and compo... |
|
|
Invention
|
Characterization of movement based on acceleration information. Systems and methods for providing... |
|
|
Invention
|
Tgfbeta signal convertor.
The present disclosure provides improved compositions for adoptive T c... |
|
|
Invention
|
Compositions and methods for treatment of melanoma. Compositions and methods for treatment of mel... |
|
|
Invention
|
Methods and systems for scaled chromatography. A method of developing a chromatography mechanisti... |
|
|
Invention
|
Methods and systems for characterizing modified oligonucleotides. Provided herein are methods for... |
|
|
Invention
|
Vegf antagonists and methods of use thereof. e.g.e.g., for treating angiogenic eye disorders. Als... |
|
|
Invention
|
Tetravalent multispecific binding molecules and methods of use thereof.
The present disclosure r... |
|
|
Invention
|
Engineered alpha klotho polypeptides and uses thereof.
The present disclosure provides engineere... |
|
|
Invention
|
Antigen-binding molecules that bind to aav particles and uses thereof. Provided herein are anti-a... |
|
|
Invention
|
Tetravalent multispecific binding molecules and methods of use thereof. The present disclosure re... |
|
|
Invention
|
Engineered alpha klotho polypeptides and uses thereof. The present disclosure provides engineered... |
|
|
Invention
|
Combination therapy to treat brain cancer.
Provided herein are methods of treating brain cancer ... |
|
|
Invention
|
Methods and systems for analysis of receptor interaction.
A computational framework for high-thr... |
|
|
Invention
|
Acceleration of human hepatocyte engraftment in humanized liver animals by supplementing paracrin... |
|
|
P/S
|
Pharmaceutical preparations and substances for the treatment and/or prevention of diseases, namel... |
|
|
Invention
|
Tumor-targeted split il12 receptor agonists.
The present disclosure relates to tumor-targeted sp... |
|
|
Invention
|
Tumor-targeted split il12 receptor agonists. The present disclosure relates to tumor-targeted spl... |
|
|
Invention
|
Mage a4 t cell receptors.
The present invention relates to an isolated T cell receptor (TCR) spe... |
|
|
Invention
|
Detecting and measuring inverted terminal repeat deletions by capillary electrophoresis. The pres... |
|
|
Invention
|
Motor assembly for drug delivery device.
A motor assembly described herein generally includes a ... |
|
|
Invention
|
Motor assembly for drug delivery device. A motor assembly described herein generally includes a s... |
|
|
Invention
|
Methods of treating multiple myeloma with bispecific bcma x cd3 antibodies. The present disclosur... |
|
|
Invention
|
Optimization method for single strand purity analysis of a sirna product. The present disclosure ... |
|
|
Invention
|
Fgfr3 binding molecules and methods of use thereof. The present disclosure relates to molecules c... |
|
|
Invention
|
Methods of treating light chain amyloidosis with bispecific bcma x cd3 antibodies. The present di... |
|
|
Invention
|
Digital health systems and methods for postural orthostatic tachycardia syndrome. Systems and met... |
|
|
Invention
|
Computational methods and systems for predicting developability of protein sequences. Described a... |
|
|
P/S
|
Syringes for medical purposes and for injections; Injection device for pharmaceuticals; Injection... |
|
|
Invention
|
Systems and methods for transcript density-based cell segmentation. Systems and methods for cell ... |
|
|
Invention
|
Transgene genomic identification by nuclease-mediated long read sequencing. Methods are provided ... |
|
|
P/S
|
Combination drug delivery devices sold full containing pharmaceutical preparations for the treatm... |
|
|
Invention
|
Non-human animals expressing exogenous terminal deoxynucleotidyltransferase.
Provided herein are... |
|
|
Invention
|
Methods for treating chronic rhinosinusitis without nasal polyps by administering an il-4r antago... |
|
|
Invention
|
Correlation of lab instrument usage with lab instrument reservations.
Systems, methods, and comp... |
|
|
Invention
|
Cell culture medium.
The present disclosure provides improved cell culture media for maintaining... |
|
|
Invention
|
Common light chain mouse.
A genetically modified mouse is provided, wherein the mouse is incapab... |
|
|
Invention
|
Anti-cd63 antibodies, conjugates, and uses thereof.
Antibodies, portions, and fusion proteins th... |
|
2024
|
Invention
|
Modified rhabdovirus glycoproteins and uses thereof.
The present disclosure provides recombinant... |
|
2023
|
Invention
|
Crispr interference therapeutics for c9orf72 repeat expansion disease.
Guide RNAs and CRISPR/Cas... |
|
|
Invention
|
Animal model of tdp-43 proteinopathy.
Described herein is the discovery that TDP-43 proteinopath... |
|
|
Invention
|
Compositions for maintaining lentiviral vector and uses thereof.
The present disclosure provides... |
|
2022
|
Invention
|
Methods of treating cancer by administering a neoadjuvant pd-1 inhibitor.
The present disclosure... |
